Published in AIDS Res Hum Retroviruses on June 01, 2004
Simian immunodeficiency virus infection of chimpanzees. J Virol (2005) 2.46
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev (2006) 2.28
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest (2008) 2.12
Adaptation of HIV-1 to its human host. Mol Biol Evol (2007) 1.77
Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol (2005) 1.66
The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci (2010) 1.54
Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2. PLoS Comput Biol (2009) 1.47
Confirmation of putative HIV-1 group P in Cameroon. J Virol (2010) 1.36
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. J Clin Microbiol (2005) 1.29
A challenge to the ancient origin of SIVagm based on African green monkey mitochondrial genomes. PLoS Pathog (2007) 1.25
Antiretroviral drug resistance in human immunodeficiency virus type 2. Antimicrob Agents Chemother (2009) 1.17
Detection and partial characterization of simian immunodeficiency virus SIVsm strains from bush meat samples from rural Sierra Leone. J Virol (2005) 1.11
In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques. Virology (2007) 1.11
The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology (2012) 1.10
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J Clin Microbiol (2005) 1.10
Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol (2012) 1.10
Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A. J Gen Virol (2011) 1.03
High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains. PLoS One (2010) 1.03
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol (2010) 1.01
Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Côte d'Ivoire. AIDS (2013) 0.99
Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings. AIDS Res Treat (2011) 0.96
Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild. J Virol (2014) 0.94
Current status of HIV/AIDS in Cameroon: how effective are control strategies? Int J Environ Res Public Health (2008) 0.93
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load. J Clin Microbiol (2014) 0.86
Isolation of a new HIV-2 group in the US. Retrovirology (2008) 0.83
Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection. PLoS One (2011) 0.83
Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1. Viruses (2012) 0.82
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration. PLoS Pathog (2015) 0.82
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. PLoS One (2012) 0.82
Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR. J Clin Microbiol (2004) 0.81
High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences. Retrovirology (2013) 0.78
Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso. PLoS One (2014) 0.78
Human immunodeficiency virus type 2 infections in Austria. Wien Klin Wochenschr (2014) 0.78
Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity. Clin Vaccine Immunol (2010) 0.77
A modular system to evaluate the efficacy of protease inhibitors against HIV-2. PLoS One (2014) 0.76
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response. Retrovirology (2013) 0.76
Molecular investigation of human immunodeficiency virus type 2 subtype a cases in South Korea. J Clin Microbiol (2006) 0.76
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activities against HIV-1, HIV-2 and Simian Immunodeficiency Virus. J Virol (2016) 0.75
A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants. J Clin Microbiol (2016) 0.75
Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates. Sci Rep (2017) 0.75
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis (2008) 5.20
The molecular population genetics of HIV-1 group O. Genetics (2004) 4.53
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis (2003) 4.51
Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med (2011) 4.03
Evolutionary relationships of wild hominids recapitulated by gut microbial communities. PLoS Biol (2010) 4.01
A new human immunodeficiency virus derived from gorillas. Nat Med (2009) 3.47
The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS One (2007) 3.27
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest (2005) 3.08
Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med (2010) 2.91
The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A (2007) 2.89
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr (2007) 2.89
Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med (2007) 2.79
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing. AIDS (2009) 2.55
Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections. Crit Care Med (2015) 2.37
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS (2002) 2.21
Population genetics provides evidence for recombination in Giardia. Curr Biol (2007) 2.13
Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One (2010) 2.10
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial. AIDS (2002) 2.03
Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog (2008) 1.92
DNA extraction from dry museum beetles without conferring external morphological damage. PLoS One (2007) 1.85
Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol (2004) 1.73
Drug resistance mutations in HIV-1. Top HIV Med (2003) 1.72
Protein-protein interaction networks and biology--what's the connection? Nat Biotechnol (2008) 1.69
Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol (2005) 1.66
Genome-wide classification and evolutionary analysis of the bHLH family of transcription factors in Arabidopsis, poplar, rice, moss, and algae. Plant Physiol (2010) 1.66
The distribution of HIV-1 recombination breakpoints. Infect Genet Evol (2007) 1.65
Crimean-Congo hemorrhagic fever, Mauritania. Emerg Infect Dis (2004) 1.65
Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr (2002) 1.63
Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses (2008) 1.61
Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol (2004) 1.61
Convergent evolution of gene networks by single-gene duplications in higher eukaryotes. EMBO Rep (2004) 1.59
Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II. BMC Bioinformatics (2012) 1.59
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study. PLoS One (2012) 1.56
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microbes Infect (2006) 1.56
Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003. Emerg Infect Dis (2007) 1.53
The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front Biosci (2004) 1.53
Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis (2009) 1.49
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe. Clin Infect Dis (2013) 1.49
Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol (2005) 1.48
The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach. PLoS Comput Biol (2010) 1.48
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients. AIDS (2008) 1.48
Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2. PLoS Comput Biol (2009) 1.47
Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study. J Acquir Immune Defic Syndr (2008) 1.46
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS (2003) 1.45
Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog (2009) 1.45
Undiagnosed HIV prevalence based on nontargeted screening in emergency departments. AIDS (2012) 1.44
Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol (2008) 1.44
Choose your partners: dimerization in eukaryotic transcription factors. Trends Biochem Sci (2008) 1.43
Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis (2006) 1.42
Identifying the important HIV-1 recombination breakpoints. PLoS Comput Biol (2008) 1.42
All duplicates are not equal: the difference between small-scale and genome duplication. Genome Biol (2007) 1.41
Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS (2003) 1.40
Specificity in protein interactions and its relationship with sequence diversity and coevolution. Proc Natl Acad Sci U S A (2007) 1.39
Drug resistance mutations in HIV-1. Top HIV Med (2004) 1.37
French experience of 2009 A/H1N1v influenza in pregnant women. PLoS One (2010) 1.35
On the origins of the extracellular matrix in vertebrates. Matrix Biol (2006) 1.35
Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol (2002) 1.32
An integrated view of molecular coevolution in protein-protein interactions. Mol Biol Evol (2010) 1.32
Questioning the evidence for genetic recombination in the 1918 "Spanish flu" virus. Science (2002) 1.30
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors. Antimicrob Agents Chemother (2008) 1.30
Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg Infect Dis (2009) 1.29
Evolutionary history of chimpanzees inferred from complete mitochondrial genomes. Mol Biol Evol (2010) 1.29
A challenge to the ancient origin of SIVagm based on African green monkey mitochondrial genomes. PLoS Pathog (2007) 1.25
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog (2013) 1.24
An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathog (2012) 1.24
HIV-1 resistance genotyping on dried serum spots. AIDS (2005) 1.23
The integrins of the urochordate Ciona intestinalis provide novel insights into the molecular evolution of the vertebrate integrin family. BMC Evol Biol (2005) 1.23
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance. J Med Virol (2006) 1.22
Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism. PLoS One (2012) 1.21
Homologous recombination in negative sense RNA viruses. Viruses (2011) 1.19
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort. AIDS (2006) 1.19
Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay. PLoS One (2010) 1.18
Reconstruction of ancestral protein interaction networks for the bZIP transcription factors. Proc Natl Acad Sci U S A (2007) 1.18
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr (2011) 1.17
Defining the role of essential genes in human disease. PLoS One (2011) 1.17
HIV-host interactions: a map of viral perturbation of the host system. AIDS (2009) 1.16
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients. Antivir Ther (2004) 1.14
Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 group O. J Acquir Immune Defic Syndr (2004) 1.14
High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen. J Med Virol (2004) 1.14
Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). J Virol (2006) 1.13
Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir. J Virol (2012) 1.13
Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. J Virol (2003) 1.13
Detection and partial characterization of simian immunodeficiency virus SIVsm strains from bush meat samples from rural Sierra Leone. J Virol (2005) 1.11
Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems. PLoS Comput Biol (2010) 1.11